JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$256.56
-0.09 (-0.04%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+54.33%
1Y
+131.66%
YTD
+48.17%
Open$257.49
Previous Close$256.65
Day High$258.38
Day Low$254.69
52W High$265.05
52W Low$105.00
Volume—
Avg Volume908.8K
Market Cap16.66B
P/E Ratio17.71
EPS$14.63
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$167.39
Above
SMA 200
$136.05
Above
RSI (14)
68.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-27.4% upside
Current
$256.56
$256.56
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.55B | 4.32B | 1.73B |
| Net Income | -379,327,485 | -324,334,729 | 500.28M |
| Profit Margin | -8.4% | -7.9% | 28.9% |
| EBITDA | 239.03M | 215.73M | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +5.3% | +5.3% | +7.8% |
| Debt/Equity | 1.24 | 1.24 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |